FREE NEWSLETTER: Econintersect sends a nightly newsletter highlighting news events of the day, and providing a summary of new articles posted on the website. Econintersect will not sell or pass your email address to others per our privacy policy. You can cancel this subscription at any time by selecting the unsubscribing link in the footer of each email.

posted on 30 October 2015

Biotech Stocks Have Now Reached Bear Market Territory

by Kyle Anderson, Money Morning

Money Morning Article of the Week

The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.

In fact, this week's latest pullback has many biotech stocks in bear market territory. Since July 20, the Nasdaq Biotechnology Index is down more than 24%. In the same time, the S&P 500 Biotechnology Select Industry Index is down 29.7%.

While the broader markets all tumbled in late August following the stock market crash in China, many have rebounded. Since Aug. 29, the S&P 500 has rebounded 2.8%.

But the biotechnology indices have only continued to fall. Here's a look at their performance since July 20, compared to the S&P 500:

Here's why biotech stocks in particular have performed so poorly lately...

Why Biotech Stocks Are Underperforming

Biotech stocks have been hammered recently as pharmaceutical companies continue to face scrutiny for high drug prices.

Martin Shkreli, CEO of Turing Pharmaceuticals, received very public criticism in September for raising the price of a life-saving medication by 5,000%. That put focus on the entire pharmaceutical sector.

Shortly after, a report from The Wall Street Journal indicated the 30 highest-selling drugs in the United States saw their prices increase roughly 76% from 2010 through 2014. During the same time, demand only rose 20%. That made it clear the price gouging was not just limited to one or two companies.

Finally, the Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock drop this week sent ripples through the market.

VRX stock has dropped more than 45% this week alone after a report from Citron Research called the company "the pharmaceutical Enron." The report alleges that Valeant engaged in a series of sham transactions to inflate its drug sales.

All three of these factors have combined to bring down biotech stocks over the last several months. The sell-off could persist as regulators continue to investigate the recent practices of major pharmaceutical companies.

>>>>> Scroll down to view and make comments <<<<<<

Click here for Historical Investing Post Listing

Make a Comment

Econintersect wants your comments, data and opinion on the articles posted.  As the internet is a "war zone" of trolls, hackers and spammers - Econintersect must balance its defences against ease of commenting.  We have joined with Livefyre to manage our comment streams.

To comment, using Livefyre just click the "Sign In" button at the top-left corner of the comment box below. You can create a commenting account using your favorite social network such as Twitter, Facebook, Google+, LinkedIn or Open ID - or open a Livefyre account using your email address.

You can also comment using Facebook directly using he comment block below.

Econintersect Investing


Print this page or create a PDF file of this page
Print Friendly and PDF

The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.

Take a look at what is going on inside of
Main Home
Analysis Blog
Rising Tide Does Not Lift All Ships
Comments on Feyerabend’s ‘Against Method’, Part II
News Blog
New Seasonal Outlook Updates from NOAA and JAMSTEC - Let's Compare Them.
Infographic Of The Day: Driving Into A Battery Powered Future
Earthquake Risk - Location Matters
Investor Alert: Be On The Lookout For Investment Scams Related To Hurricane Matthew
Lost In Translation: Five Common English Phrases You May Be Using Incorrectly
The Size And Scope Of Samsung's Business
Immigration Is The Top Worry For Britons
People Killed By Russian Airstrikes In Syria
Have You Taken These 4 Simple Steps To Improve Your Trading?
14 October 2016: ECRI's WLI Growth Index Insignificantly Declines
Mom Breaks Down In Tears When Son With Autism Meets Service Dog
Rail Week Ending 15 October 2016 Paints A Negative Economic View
What Is The New Normal For U.S. Growth?
Investing Blog
FinTech Is Taking A Bite Out Of Banks
Options Early Assignment - Should You Worry?
Opinion Blog
US 2016 Election: Will US-China Relations Change
Prop. 51 Versus A State-Owned Bank: How California Can Save $10 Billion On A $9 Billion Loan
Precious Metals Blog
How Will The Election Outcome Impact Precious Metals?
Live Markets
21Oct2016 Market Close: Major US Indexes Close Flat On Low Volume, Crude Prices Resume Climb, US Dollar Stabilizes In Mid 98 Handle, Yes, Most Investors Are Worried Which Way This Market Will Go
Amazon Books & More

.... and keep up with economic news using our dynamic economic newspapers with the largest international coverage on the internet
Asia / Pacific
Middle East / Africa
USA Government

Crowdfunding ....



Analysis Blog
News Blog
Investing Blog
Opinion Blog
Precious Metals Blog
Markets Blog
Video of the Day


Asia / Pacific
Middle East / Africa
USA Government

RSS Feeds / Social Media

Combined Econintersect Feed

Free Newsletter

Marketplace - Books & More

Economic Forecast

Content Contribution



  Top Economics Site Contributor TalkMarkets Contributor Finance Blogs Free PageRank Checker Active Search Results Google+

This Web Page by Steven Hansen ---- Copyright 2010 - 2016 Econintersect LLC - all rights reserved